BIGGER CAPITAL FUND L P 13D/13G Filings for Actinium Pharmaceuticals, Inc. (ATNM)

BIGGER CAPITAL FUND L P 13D and 13G filings for Actinium Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-06
4:28 pm
Purchase
2022-12-3113GActinium Pharmaceuticals, Inc.
ATNM
BIGGER CAPITAL FUND L P1,691,667
6.600%
377,561increase
(+28.73%)
Filing
2022-02-08
8:53 pm
Purchase
2021-12-3113GActinium Pharmaceuticals, Inc.
ATNM
BIGGER CAPITAL FUND L P1,314,106
6.000%
380,478increase
(+40.75%)
Filing
2021-02-12
4:30 pm
Purchase
2020-12-3113GActinium Pharmaceuticals, Inc.
ATNM
BIGGER CAPITAL FUND L P933,628
6.900%
128,569increase
(+15.97%)
Filing
2020-08-11
5:37 pm
Purchase
2020-08-0513GActinium Pharmaceuticals, Inc.
ATNM
BIGGER CAPITAL FUND L P805,059
5.900%
805,059increase
(New Position)
Filing